Jun 16, 2022 / 03:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Great. Welcome, everybody. I'm Matt Sykes, the life science tools and diagnostics analyst at Goldman Sachs, and I have the pleasure of welcoming Quanterix to our conference this morning. We have Masoud Toloue, the Chief Executive Officer; and Mike Doyle, the Chief Financial Officer. Masoud, Mike, thanks for joining us today.
Michael A. Doyle - Quanterix Corporation - CFO & Treasurer
Matt, we appreciate being here.
Masoud Toloue - Quanterix Corporation - President, CEO & Director
Great to see in person.
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Yes, finally a long time. Mike, I don't know if you have any forward...
Michael A. Doyle - Quanterix Corporation - CFO & Treasurer
Quick comments that, obviously, our discussions today are covered by our forward-looking statements and it's on our
Quanterix Corp at Goldman Sachs Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
